⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for multidrug resistance

Every month we try and update this database with for multidrug resistance cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Pilot Study of 18F Fluoropaclitaxel (FPAC)NCT00572598
Breast Cancer
4- [F-18] fluor...
18 Years - 90 YearsVirginia Commonwealth University
Study of TPI 287 Administered Every 21 Days in Patients With Advanced MalignanciesNCT00256191
Neoplasms
Hodgkin's Disea...
Non-Hodgkin's L...
TPI 287 Injecti...
18 Years - 85 YearsCortice Biosciences, Inc.
A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical ResectionNCT00001339
Adrenal Cortica...
doxorubicin, vi...
- National Institutes of Health Clinical Center (CC)
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833NCT00001383
Breast Cancer
Cancer
Carcinoma, Rena...
Lymphoma
Ovarian Cancer
PSC 833
paclitaxel
- National Institutes of Health Clinical Center (CC)
Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast CancerNCT00001493
Breast Neoplasm...
Neoplasm Metast...
peripheral bloo...
- National Institutes of Health Clinical Center (CC)
A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical ResectionNCT00001339
Adrenal Cortica...
doxorubicin, vi...
- National Institutes of Health Clinical Center (CC)
Pilot Study of 18F Fluoropaclitaxel (FPAC)NCT00572598
Breast Cancer
4- [F-18] fluor...
18 Years - 90 YearsVirginia Commonwealth University
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833NCT00001383
Breast Cancer
Cancer
Carcinoma, Rena...
Lymphoma
Ovarian Cancer
PSC 833
paclitaxel
- National Institutes of Health Clinical Center (CC)
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833NCT00001302
Breast Cancer
Kidney Neoplasm
Lymphoma
Neoplasm Metast...
Ovarian Cancer
PSC 833
- National Institutes of Health Clinical Center (CC)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: